Minerva Neurosciences Reports Fiscal 2016 Fourth Quarter and Year End Financial Results and Business Updates

Go back to Minerva Neurosciences Reports Fiscal 2016 Fourth Quarter and Year End Financial Results and Business Updates

Minerva Neurosciences (NERV) Misses Q4 EPS by 2c

March 13, 2017 7:36 AM EDT

Minerva Neurosciences (NASDAQ: NERV) reported Q4 EPS of ($0.27), $0.02 worse than the analyst estimate of ($0.25).

For earnings history and earnings-related data on Minerva Neurosciences (NERV) click here.

... More